Metabolic syndrome (MS) is a cluster of several risk factors such as abdominal obesity, hypertension, dyslipidemia, insulin resistance and considered risk for the development of the type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Knowing contemporary aspects of the development of this disease allows understanding underlining mechanisms of the MS. This review summarizes modern concepts of the metabolic syndrome and its etiology, pathogenesis and biochemical mechanisms of the development of the metabolic disease.
Pathogenetic mechanisms of development of MS
The founder of the modern concept of MS is an American scientist Gerald Riven (Jerald Reaven), who proposed in 1988 an elegant pathophysiological model for the development of MS, in which the IR phenomenon was called the key factor in the emergence of this condition [15] .
The term "insulin resistance" (IR) is understood to mean a decrease in the response of insulin-sensitive tissues to insulin at its sufficient concentration, leading to chronic compensatory hyperinsulinemia. IR is based on various genetic defects responsible for transmitting the signal after insulin combines with its receptor (post-receptor defects) [16] . Normally, autophosphorylation of the receptor occurs with the participation of tyrosine kinase and its subsequent connection with the substrate of the insulin receptor (IRS-1 and -2). IRS molecules activate phosphatidylinositol-3-kinase (PI3K), which stimulates the translocation of glucose transporter GLUT-4 across the cell membrane, which ensures the activation of the metabolic and mitogenic effects of insulin [17] . In patients with IR and type 2 diabetes, the translocation of the glucose transporter is disrupted, and the expression of other genes responsible for the metabolism of glucose and lipids, including mutations of glycogen synthetase genes, hormone-sensitive lipase, tumor necrosis factor (TNF) alpha, uncoupling protein, etc., is disturbed.
It is difficult to find the only root because in the pathogenesis of MS, they are so closely interconnected and interdependent. The basis of MS is insulin resistance (IR) or impaired biological response of body tissues to insulin action, accompanied by a decrease in glucose consumption by tissues. At the same time, the non-oxidative way of consuming this carbohydrate is disturbed to a greater extent -glycogen synthesis, which is a result of the interaction of genetic (defect insulin receptors) and external factors, especially the formation of androgenic obesity and a decrease in blood volume in the capillaries of skeletal muscle as a result of their vasoconstriction, and this affects by increasing the diffusion pathway of glucose to the cells [18] . Target organs of hypertension in people with obesity are affected much earlier, and their changes are much more pronounced than in patients with hypertension without obesity [19] . Scientists have proven that IR and concomitant hyperinsulinemia trigger a number of pathological reactions that are closely associated with endothelial dysfunction and form a vicious circle leading to metabolic diseases [20] . One of the key conditions in the formation of metabolic disorders in MS is the abdominal type of obesity (since an increased amount of visceral fat is combined with IR, hyperinsulinemia (GI), dyslipidemia, and arterial hypertension). In this case, adipose tissue can be considered as a neuroimmune-endocrine organ producing leptin [21] . Leptin, in turn, acts on the centers of hunger and saturation in the hypothalamus, participates in the regulation of energy homeostasis and controls body weight. Researchers believe that obesity causes compensatory resistance of the hypothalamus to the central action of leptin, and, subsequently, through a negative feedback mechanism leads to hyperleptinemia. It is believed that leptin is a link between adipocytes and P-cells of the pancreas and stimulates insulin secretion while reducing sensitivity to the latter. At the same time, leptin level is a signal marker of sufficient accumulation of adipose tissue [22] .
Factors affecting the development of MS are well known in modern medicine. This is, first of all, the consumption of large amounts of high-calorie foods and low physical activity. The basis of abdominal obesity is excessive consumption of animal fats containing saturated fatty acids. If the mass of fat consumed exceeds the body's ability to oxidize it, obesity develops and progresses. Saturated fatty acids in excess with food cause structural changes in the phospholipids of cell membranes and disrupt the expression of genes that control the insulin signal in the cell [6, 9] . In the diet of modern man, there are fewer food products in their natural form, and more processed foods that require a significant amount of oil for cooking, as well as industrial-grade dishes rich in easily digestible carbohydrates. A popular contribution to the development of the disease is the popularization of "fast food" ("fast food"), high-calorie drinks and computerization of leisure. The most important environmental factor is the excessive consumption of animal fats containing saturated fatty acids [23] .
About 30-40% of patients with obesity have food disorders, among which the most common are hyperphagic stress response, compulsive hyperphagia, carbohydrate thirst and premenstrual hyperphagia. Hyperphagic reaction to stress, as a eating disorder is manifested by the fact that during psycho-emotional stress, anxiety, or immediately after the effect of the factor causing stress, the person suddenly increases appetite, and there is a desire to eat. In compulsive hyperphagia, patients periodically, for no reason, or for reasons they are not aware of, consume a large amount of food, often sweet and fatty. This type of disturbance includes night hyperphagia -an imperative increase in appetite in the evening and at night. To satisfy carbohydrate or food thirst, patients require both sugary and fatty foods (chocolate, ice cream, cream, etc.). In its absence, patients develop a depressive state, resembling abstinence. The mechanisms of the occurrence of food disorders are associated with a violation of serotonin transmission in brain structures responsible for the regulation of eating behavior [24] . At the same time, excessive fat intake can be formed as a family nutrition habit transmitted by education. Unfortunately, the number of obese families in recent times is becoming increasingly common.
As is known, the predisposition to the development of obesity is to reduce the ability to oxidize fat. One possible reason is the condition of the muscles and the composition of the muscle fibers. The bulk of body fat is oxidized in muscle tissue, in its slow and fast oxidative fibers, while fast glycolytic fibers in muscles are deprived of this ability. Obviously, with the predominance of this type of fibers in the muscles, the ability to oxidize lipids will be reduced [25] .
The decrease in physical activity is the second most important after overeating environmental factor contributing to the development of obesity and IR. When hypodynamia occurs, lipolysis and utilization of triglycerides in muscle and adipose tissue slow down and translocation of glucose transporters in muscles decreases, which leads to the development of IR.
Genetic risk factors may also consist in the constitutional characteristics of the composition of muscle fibers, the distribution of fat, activity and insulin sensitivity of the main enzymes of carbohydrate and fat metabolism. The formation of MS is determined by a genetic predisposition to several groups of candidate genes [26] . One of these groups includes genes whose products determine elevated glucose levels. The number of candidate genes that can potentially influence the action of insulin is very large. Both in the signal chain of insulin action and in the processes of glucose uptake and metabolism, various proteins are involved, any change of which may affect insulin sensitivity [27] .
Separately, it is necessary to single out a group of genes whose products regulate lipid metabolism and the development of obesity. At present, it is assumed that genes encoding apolipoprotein (a fatty acid carrier linked to cell membranes) can be associated with the development of MS [28] .
The group of genes for which significant association with essential hypertension was found includes genes encoding angiotensinogen, the P-protein subunit and NO-synthetase of vascular endothelial cells [29] .
The reasons for the widespread mutation of the mutations described above are not completely clear, but most researchers support the "economical genotype" theory put forward by Professor James Neel in 1962 [30] . According to this hypothesis, in the course of evolution, the most appropriate "thrift" genes were fixed in the genotype, providing IL with the aim of accumulating energy in the form of fat "in reserve". Under the primitive communal system, this process had an adaptive meaning for survival in conditions where the human nutritional capacity was irregular and the periods of abundance alternated with periods of prolonged starvation. However, for a very short -on the scale of evolution -a period of time in countries with a high standard of living, humanity switched to high-calorie nutrition combined with a decrease in the expenditure of muscle energy. The result of the mechanism of IR fixed in the genetic memory is the development of an MS pandemic, including its main components: obesity, dyslipidemia, arterial hypertension and type 2 diabetes.
Scientific studies have shown that excess adipose tissue, which has an auto-, para-and endocrine function is the basis for the development and progression of IR and is itself capable of secreting a large number of cytokines and vasoactive substances. To date, the most studied are leptin and adiponectin. Medications for chronic subacute inflammation also include TNF-alpha, C-reactive protein, interleukins (IL) 1, 6, and 8 [30] .
Until now, the etiology and pathogenesis of MS are not fully disclosed. The publications containing the results of scientific studies describe various hormonal disorders that contribute to the development of abdominal obesity, including activation of the hypothalamic-pituitary-adrenal axis, an increase in testosterone and androstenedione, and a decrease in progesterone production in women, a decrease in testosterone and dihydrotestosterone in men, a decrease in growth hormone, increase in production of norepinephrine, contributing to the activation of the sympathetic nervous system [31] .
Speaking about the pathogenetic mechanisms of MS development, it is impossible not to note the important role of endothelial dysfunction (ED). The term "endothelial dysfunction" refers to a decrease in the ability of endothelial cells to secrete relaxing factors while maintaining or increasing the level of production of vasoconstrictor factors, one of which is nitric oxide. Dysfunction of the vascular endothelium is one of the leading links in the development of atherosclerosis [32] . The final answer on the primary or secondary role of ED in the onset of RI is not currently received.
Thus, decoding the polygenic nature of inheritance, the study of the main etiological and pathogenetic mechanisms of MS is a priority scientific direction for scientists around the world. Summarizing the information presented, it can be concluded that metabolic syndrome has a widespread pathology that contains a set of pathogenetically interdependent disorders that are currently not studied in detail. Significant deviations from the norm of the main metabolic and hormonal parameters in obese people indicate a multiorgan
